Stay updated on QL1706 in Nasopharyngeal Carcinoma: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the QL1706 in Nasopharyngeal Carcinoma: Efficacy Study Clinical Trial page.

Latest updates to the QL1706 in Nasopharyngeal Carcinoma: Efficacy Study Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history shows a new version (v3.3.2) replacing v3.3.1, with sponsor details (Qilu Pharmaceutical Co., Ltd.) and status notes (Verified; Unknown status).SummaryDifference1.0%

- Check21 days agoChange DetectedThe page shows a revision history update from v3.2.0 to v3.3.1; this is a minor release/version update and does not affect study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe funding-lapse notice banner present in the old version was removed, leaving the page with only the standard government disclaimer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check43 days agoChange DetectedVersion 2 (2022-10-21) updated Study Status and Eligibility. Version 3 (2023-11-21) updated Recruitment Status, Study Status, and Contacts/Locations.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference13%

- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to QL1706 in Nasopharyngeal Carcinoma: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QL1706 in Nasopharyngeal Carcinoma: Efficacy Study Clinical Trial page.